Latest Insider Transactions at Cme Group Inc. (CME)
This section provides a real-time view of insider transactions for Cme Group Inc. (CME). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CME GROUP INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CME GROUP INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 12
2024
|
Elizabeth A Cook Director |
SELL
Open market or private sale
|
Indirect |
750
-3.95%
|
$169,500
$226.33 P/Share
|
|
Nov 04
2024
|
Martin J Gepsman Director |
SELL
Open market or private sale
|
Direct |
400
-1.57%
|
$88,800
$222.92 P/Share
|
|
Oct 30
2024
|
Sunil Cutinho Chief Information Officer |
SELL
Open market or private sale
|
Direct |
4,500
-14.26%
|
$1,017,000
$226.64 P/Share
|
|
Oct 30
2024
|
Timothy S. Bitsberger Director |
SELL
Open market or private sale
|
Direct |
1,000
-4.41%
|
$226,000
$226.96 P/Share
|
|
Oct 28
2024
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
SELL
Open market or private sale
|
Direct |
1,374
-15.89%
|
$311,898
$227.12 P/Share
|
|
Sep 25
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
12
+0.51%
|
$2,616
$218.5 P/Share
|
|
Sep 25
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
280
+0.11%
|
$61,040
$218.5 P/Share
|
|
Sep 16
2024
|
Terrence A Duffy Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
27,456
+22.44%
|
$5,985,408
$218.53 P/Share
|
|
Sep 16
2024
|
Julie Holzrichter Sr MD Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+8.18%
|
$785,672
$218.53 P/Share
|
|
Sep 16
2024
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+23.41%
|
$785,672
$218.53 P/Share
|
|
Sep 16
2024
|
Julie Winkler Sr MD Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+9.72%
|
$785,672
$218.53 P/Share
|
|
Sep 16
2024
|
Jack J Tobin MD Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
852
+3.49%
|
$185,736
$218.53 P/Share
|
|
Sep 16
2024
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
BUY
Grant, award, or other acquisition
|
Direct |
3,088
+26.31%
|
$673,184
$218.53 P/Share
|
|
Sep 16
2024
|
Michael G. Dennis Global Head of Fixed Income |
BUY
Grant, award, or other acquisition
|
Direct |
2,744
+30.28%
|
$598,192
$218.53 P/Share
|
|
Sep 16
2024
|
Jonathan L Marcus Sr MD General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,744
+27.14%
|
$598,192
$218.53 P/Share
|
|
Sep 16
2024
|
Hilda Harris Piell Sr MD & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,088
+9.05%
|
$673,184
$218.53 P/Share
|
|
Sep 16
2024
|
Lynne Fitzpatrick Sr MD Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+17.61%
|
$785,672
$218.53 P/Share
|
|
Sep 16
2024
|
Sunil Cutinho Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+10.25%
|
$785,672
$218.53 P/Share
|
|
Sep 16
2024
|
Ken Vroman Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,088
+12.42%
|
$673,184
$218.53 P/Share
|
|
Sep 16
2024
|
Suzanne Sprague Sr MD Global Head of Clearing |
BUY
Grant, award, or other acquisition
|
Direct |
3,088
+24.46%
|
$673,184
$218.53 P/Share
|
|
Sep 15
2024
|
Julie Holzrichter Sr MD Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,583
-4.12%
|
$341,928
$216.99 P/Share
|
|
Sep 15
2024
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Payment of exercise price or tax liability
|
Direct |
1,506
-15.54%
|
$325,296
$216.99 P/Share
|
|
Sep 15
2024
|
Julie Winkler Sr MD Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,467
-4.68%
|
$316,872
$216.99 P/Share
|
|
Sep 15
2024
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
252
-1.1%
|
$54,432
$216.99 P/Share
|
|
Sep 15
2024
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
SELL
Payment of exercise price or tax liability
|
Direct |
886
-13.74%
|
$191,376
$216.99 P/Share
|
|
Sep 15
2024
|
Jonathan L Marcus Sr MD General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
271
-5.54%
|
$58,536
$216.99 P/Share
|
|
Sep 15
2024
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,314
-4.49%
|
$283,824
$216.99 P/Share
|
|
Sep 15
2024
|
Lynne Fitzpatrick Sr MD Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
754
-5.38%
|
$162,864
$216.99 P/Share
|
|
Sep 15
2024
|
Sunil Cutinho Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,546
-5.24%
|
$333,936
$216.99 P/Share
|
|
Sep 15
2024
|
Ken Vroman Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,292
-6.46%
|
$279,072
$216.99 P/Share
|
|
Sep 15
2024
|
Suzanne Sprague Sr MD Global Head of Clearing |
SELL
Payment of exercise price or tax liability
|
Direct |
755
-10.48%
|
$163,080
$216.99 P/Share
|
|
Sep 03
2024
|
Bryan T Durkin Director |
SELL
Bona fide gift
|
Direct |
465
-0.84%
|
-
|
|
Aug 30
2024
|
Bryan T Durkin Director |
SELL
Open market or private sale
|
Direct |
7,593
-12.01%
|
$1,624,902
$214.59 P/Share
|
|
Jun 25
2024
|
William W Hobert Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,237
+1.42%
|
$239,978
$194.1 P/Share
|
|
Jun 25
2024
|
Deborah J Lucas Director |
BUY
Grant, award, or other acquisition
|
Direct |
748
+13.35%
|
$145,112
$194.1 P/Share
|
|
Jun 25
2024
|
Elizabeth A Cook Director |
BUY
Grant, award, or other acquisition
|
Indirect |
748
+3.79%
|
$145,112
$194.1 P/Share
|
|
Jun 25
2024
|
Rahael Seifu Director |
BUY
Grant, award, or other acquisition
|
Direct |
748
+17.36%
|
$145,112
$194.1 P/Share
|
|
Jun 25
2024
|
Terry L Savage Director |
BUY
Grant, award, or other acquisition
|
Indirect |
748
+3.95%
|
$145,112
$194.1 P/Share
|
|
Jun 25
2024
|
Phyllis M Lockett Director |
BUY
Grant, award, or other acquisition
|
Direct |
748
+15.22%
|
$145,112
$194.1 P/Share
|
|
Jun 25
2024
|
Larry G Gerdes Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,237
+2.95%
|
$239,978
$194.1 P/Share
|
|
Jun 25
2024
|
Daniel G Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
748
+15.22%
|
$145,112
$194.1 P/Share
|
|
Jun 25
2024
|
Dennis Suskind Director |
BUY
Grant, award, or other acquisition
|
Direct |
748
+16.04%
|
$145,112
$194.1 P/Share
|
|
Jun 25
2024
|
Martin J Gepsman Director |
BUY
Grant, award, or other acquisition
|
Direct |
748
+2.85%
|
$145,112
$194.1 P/Share
|
|
Jun 25
2024
|
Kathryn Benesh Director |
BUY
Grant, award, or other acquisition
|
Direct |
748
+32.42%
|
$145,112
$194.1 P/Share
|
|
Jun 25
2024
|
Timothy S. Bitsberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
748
+6.06%
|
$145,112
$194.1 P/Share
|
|
Jun 25
2024
|
Bryan T Durkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
748
+1.17%
|
$145,112
$194.1 P/Share
|
|
Jun 25
2024
|
Howard J Siegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,237
+2.57%
|
$239,978
$194.1 P/Share
|
|
Jun 25
2024
|
Patrick J Mulchrone Director |
BUY
Grant, award, or other acquisition
|
Direct |
748
+2.61%
|
$145,112
$194.1 P/Share
|
|
Jun 25
2024
|
Charles P Carey Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,237
+12.84%
|
$239,978
$194.1 P/Share
|
|
Jun 25
2024
|
Michael G. Dennis Global Head of Fixed Income |
BUY
Grant, award, or other acquisition
|
Direct |
748
+17.3%
|
$145,112
$194.1 P/Share
|